MDGS
Price:
$2.36
Market Cap:
$4.47M
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management an...[Read more]
Industry
Medical - Devices
IPO Date
2015-08-05
Stock Exchange
NASDAQ
Ticker
MDGS
According to Medigus Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.27. This represents a change of 9.97% compared to the average of -0.25 of the last 4 quarters.
The mean historical PE Ratio of Medigus Ltd. over the last ten years is 6.35. The current -0.27 PE Ratio has changed -526.91% with respect to the historical average. Over the past ten years (40 quarters), MDGS's PE Ratio was at its highest in in the December 2017 quarter at 53.18. The PE Ratio was at its lowest in in the June 2022 quarter at -21.67.
Average
6.35
Median
-0.59
Minimum
-37.21
Maximum
113.87
Discovering the peaks and valleys of Medigus Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 113.87
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -37.21
Year | PE Ratio | Change |
---|---|---|
2023 | -0.34 | -53.88% |
2022 | -0.74 | -100.65% |
2021 | 113.87 | -406.03% |
2020 | -37.21 | 288.08% |
2019 | -9.59 | 1.08% |
2018 | -0.81 | -32.40% |
2017 | -1.20 | 178.70% |
2016 | -0.43 | -Infinity% |
2015 | 0 | 0% |
2014 | 0 | 0% |
The current PE Ratio of Medigus Ltd. (MDGS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
37.59
5-year avg
13.20
10-year avg
6.35
Medigus Ltd.’s PE Ratio is less than BrainsWay Ltd. (110.33), greater than Delcath Systems, Inc. (-8.22), greater than Heska Corporation (-67.36), greater than Paragon 28, Inc. (-13.77), greater than Nexalin Technology, Inc. (-7.46), greater than Bluejay Diagnostics, Inc. (-3.92), greater than INVO Bioscience, Inc. (-0.42), greater than Motus GI Holdings, Inc. (-0.65), greater than IRIDEX Corporation (-2.70), greater than IceCure Medical Ltd (-2.54), less than BrainsWay Ltd. (110.33), greater than ProSomnus, Inc. Common Stock (-0.59), greater than Surmodics, Inc. (-48.35), greater than STRATA Skin Sciences, Inc. (-1.31), greater than PetVivo Holdings, Inc. (-1.21), less than Dynatronics Corporation (-0.25), less than Tenon Medical, Inc. (-0.16), less than Nortech Systems Incorporated (6.34), less than Nuwellis, Inc. (-0.11), greater than ReShape Lifesciences Inc. (-0.40), greater than Ra Medical Systems, Inc. (-1.15),
Company | PE Ratio | Market cap |
---|---|---|
110.33 | $186.03M | |
-8.22 | $312.06M | |
-67.36 | $1.31B | |
-13.77 | $838.76M | |
-7.46 | $49.13M | |
-3.92 | $1.89M | |
-0.42 | $3.25M | |
-0.65 | $5.11K | |
-2.70 | $29.95M | |
-2.54 | $35.27M | |
110.33 | $118.41M | |
-0.59 | $8.18M | |
-48.35 | $561.12M | |
-1.31 | $12.72M | |
-1.21 | $10.00M | |
-0.25 | $943.95K | |
-0.16 | $7.97M | |
6.34 | $28.72M | |
-0.11 | $5.29M | |
-0.40 | $3.96M | |
-1.15 | $3.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigus Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medigus Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Medigus Ltd.'s PE Ratio?
How is the PE Ratio calculated for Medigus Ltd. (MDGS)?
What is the highest PE Ratio for Medigus Ltd. (MDGS)?
What is the 3-year average PE Ratio for Medigus Ltd. (MDGS)?
What is the 5-year average PE Ratio for Medigus Ltd. (MDGS)?
How does the current PE Ratio for Medigus Ltd. (MDGS) compare to its historical average?